MANTOAN, BARBARA
 Distribuzione geografica
Continente #
NA - Nord America 1.636
EU - Europa 1.402
AS - Asia 596
AF - Africa 18
SA - Sud America 9
OC - Oceania 4
Totale 3.665
Nazione #
US - Stati Uniti d'America 1.610
DE - Germania 310
IT - Italia 307
CN - Cina 295
AT - Austria 169
SG - Singapore 166
SE - Svezia 153
IE - Irlanda 137
FR - Francia 82
UA - Ucraina 79
FI - Finlandia 65
KR - Corea 41
JP - Giappone 27
GB - Regno Unito 26
CA - Canada 21
PL - Polonia 20
IN - India 17
SN - Senegal 16
VN - Vietnam 15
NL - Olanda 12
GR - Grecia 11
BE - Belgio 8
HK - Hong Kong 7
RU - Federazione Russa 7
ES - Italia 6
ID - Indonesia 6
IR - Iran 6
BR - Brasile 4
AU - Australia 3
CH - Svizzera 3
PK - Pakistan 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
AR - Argentina 2
MX - Messico 2
PR - Porto Rico 2
TR - Turchia 2
BD - Bangladesh 1
BG - Bulgaria 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
CU - Cuba 1
CZ - Repubblica Ceca 1
GH - Ghana 1
IL - Israele 1
KH - Cambogia 1
KW - Kuwait 1
MD - Moldavia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PT - Portogallo 1
RO - Romania 1
RS - Serbia 1
TG - Togo 1
VE - Venezuela 1
Totale 3.665
Città #
Chandler 296
Beijing 169
Vienna 168
Dublin 136
Singapore 130
Santa Clara 100
Torino 96
Ashburn 75
Nyköping 66
Jacksonville 55
Villeurbanne 53
Houston 52
Dearborn 50
Medford 48
San Mateo 43
Florence 41
Princeton 40
Fairfield 39
Wilmington 37
Ann Arbor 34
Columbus 32
Turin 28
Fremont 27
Woodbridge 25
Redwood City 22
Munich 18
Nürnberg 16
Warsaw 16
Cambridge 13
Milan 13
Washington 13
Boston 11
Guangzhou 11
Toronto 11
Norwalk 10
Seattle 9
Hyderabad 8
Nanjing 8
Pisa 8
Dong Ket 7
Nutley 7
Ottawa 7
Boardman 6
Brussels 6
Hebei 6
Jakarta 6
Shanghai 6
Tokyo 6
Duncan 5
Rome 5
San Diego 5
Verona 5
Chennai 4
Dronten 4
Düsseldorf 4
Helsinki 4
Naples 4
Changchun 3
Chengdu 3
Hangzhou 3
Hong Kong 3
Leawood 3
Los Angeles 3
Monza 3
Mountain View 3
Ningbo 3
San Francesco 3
San Francisco 3
Sao Jose do Rio Preto 3
Shenyang 3
Wuhan 3
Assago 2
Baran 2
Bologna 2
Bresso 2
Changsha 2
Cocconato 2
Collegeville 2
Edinburgh 2
Falls Church 2
Flushing 2
Guadalupe 2
Jinan 2
Karachi 2
Kunming 2
Lausanne 2
Lille 2
Manchester 2
Marseille 2
Massapequa Park 2
Moscow 2
Nagoya 2
New York 2
Odesa 2
Peabody 2
Philadelphia 2
Schifferstadt 2
Shaoxing 2
St Petersburg 2
Tianjin 2
Totale 2.224
Nome #
Persistence of minimal residual disease in bone marrow predicts outcome in follicular lymphomas treated with a rituximab-intensive program 278
Highly sensitive MYD88 l265p mutation detection by droplet digital polymerase chain reaction in waldenström macroglobulinemia 202
Centralized Biobanking Supports Hematology Clinical Trials: the new challenge of the University of Torino 191
Brief Chemoimmunotherapy R-FND with Rituximab Consolidation Followed by Randomization Between Rituximab Maintenance Vs. Observation As First Line Treatment in Elderly Patients with Advanced Follicular Lymphoma (FL): Final Results of a Prospective Randomized Trial by Italian Lymphoma Foundation (FIL) 151
Front-Line Brief Chemo-Immunotherapy Rituximab (R)-FND + Rituximab Consolidation ± Rituximab Maintenance in Elderly Patients with Untreated Advanced Stage Follicular Lymphoma (FL): First Interim Analysis of a Prospective Randomized Study (ML17638) 149
TELOMERES SHORTEN DURING CHRONIC LYMPHOCYTIC LEUKEMIA(CLL) EVOLUTION: AN ANALYSIS ON 88 CASES 131
Rituximab-Supplemented High-Dose Sequential Chemotherapy (HDS) Has Superior Response Rate and Event-Free Survival (EFS) Compared to R-CHOP in Poor Risk Follicular Lymphoma (FL) at Diagnosis: Results from a Multicenter Randomized GITMO Trial 128
Cells carrying nonlymphoma-associated bcl-2/IgH rearrangements (NLABR) are phenotypically related to follicular lymphoma and can establish as long-term persisting clonal populations 115
Ficoll-hypaque separation vs whole blood lysis: Comparison of efficiency and impact on minimal residual disease analysis 113
Long-Term Monitoring of Cancer-Free Subjects Carrying Non-Lymphoma Associated bcl2/IgH Rearrangements (NLABR): Prolonged Persistence of Clonal Populations Potentially Related to Follicular Lymphoma (FL) 112
Characteristics of the Immunoglobulin Heavy Chain (IgH) Rearrangement in Multiple Myeloma (MM): An Analysis On 308 Cases 110
Progressive Telomere Shortening Is Part of the Natural History of Chronic Lymphocytic Leukemia (CLL) and Impacts Clinical Outcom 109
Minimal Residual Disease Detection by Droplet Digital PCR in Multiple Myeloma, Mantle Cell Lymphoma, and Follicular Lymphoma: A Comparison with Real-Time PCR 105
Immunoglobulin (Ig) Repertoire in Multiple Myeloma: High Frequency of Recurrent Aminoacid Substitutions in the FR2 and CDR2 103
Telomere lenght measurement in the clinically oriented research setting: a comparison between Southern blot (SB), real time quantitative PCR (RQ-PCR) and FLOW-FISH (FF) 101
MYD88L265P MUTATION DETECTION IN WALDENSTRÖM MACROGLOBULINEMIA BY DROPLET DIGITAL PCR: MINIMAL RESIDUAL DISEASE MONITORING AND CHARACTERIZATION ON CIRCULATING FREE DNA 101
Expression of telomeric proteins in chronic lymphocytic leukemia (CLL) 98
Progressive telomere shortening is part of the natural history of chronic lymphocytic leukaemia and impacts clinical outcome: Evidences from long term follow-up 87
Minimal Residual Disease after Conventional Treatment Significantly Impacts on Progression-Free Survival of Patients with Follicular Lymphoma: The FIL FOLL05 Trial 86
Rituximab induces effective clearance of minimal residual disease in molecular relapses of mantle cell lymphoma 83
Comparison of different DNA extraction methods from peripheral blood cells: advices from the Fondazione Italiana Linfomi - MRD Network. 83
Comparison of two real-time quantitative polymerase chain reaction strategies for minimal residual disease evaluation in lymphoproliferative disorders: correlation between immunoglobulin gene mutation load and real-time quantitative polymerase chain reaction performance. 82
Minimal residual disease (MRD) in non-Hodgkin lymphomas: Interlaboratory reproducibility on marrow samples with very low levels of disease within the FIL (Fondazione Italiana Linfomi) MRD Network 81
Multiple myeloma shows no intra-disease clustering of immunoglobulin heavy chain genes 80
Telomere length correlates with histopathogenesis according to the germinal center in mature B-cell lymphoproliferative disorders 78
Cyclooxygenase-2 (COX-2) is frequently expressed in multiple myeloma and is an independent predictor of poor outcome 76
Adherence of Candida albicans and Candida dubliniensis to buccal and vaginal cells. 70
Clinical implications and prognostic role of minimal residual disease detection in follicular lymphoma 65
Minimal residual disease detection in lymphoma and multiple myeloma: impact on therapeutic paradigms 64
null 64
Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma 64
Real-time polymerase chain reaction of immunoglobulin rearrangements for quantitative evaluation of minimal residual disease in myeloma 57
Droplet digital PCR quantification of mantle cell lymphoma follow-up samples from four prospective trials of the european MCL network 57
Punctual and kinetic MRD analysis from the Fondazione Italiana Linfomi MCL0208 phase III trial in mantle cell lymphoma 54
Prolonged survival in the absence of disease-recurrence in advanced-stage follicular lymphoma following chemo-immunotherapy: 13-year update of the prospective, multicenter randomized GITMO-IIL trial 53
Differences in extracellular enzymatic activity between Candida dubliniensis and Candida albicans isolates. 50
Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma 47
Recurrence of Bcl-2/IgH polymerase chain reaction positivity following a prolonged molecular remission can be unrelated to the original follicular lymphoma clone. 42
Quality Assessment for PCR-based Minimal Residual Disease in Lymphoma: 10 Years of Cross-laboratory Standardization Process Within the Fondazione Italiana Linfomi MRD Network 37
Rituximab-based pre-emptive treatment of molecular relapse in follicular and mantle cell lymphoma. 27
Totale 3.784
Categoria #
all - tutte 11.704
article - articoli 0
book - libri 0
conference - conferenze 3.699
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.403


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020309 0 0 0 0 30 48 61 40 33 43 33 21
2020/2021352 46 31 18 17 26 18 16 13 35 38 55 39
2021/2022535 13 12 14 39 18 18 96 27 11 63 127 97
2022/2023793 95 90 10 94 48 191 49 52 74 31 29 30
2023/2024329 62 69 27 20 28 39 7 22 1 12 8 34
2024/2025392 5 26 45 88 228 0 0 0 0 0 0 0
Totale 3.784